Cancer clinical trials in the region Grand Est
191 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 1 / Phase 2
Pancreas cancer
#NCT05706129
Adenocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Breast cancer
Lung cancer
#NCT05706129
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT05706129
Urothelial carcinoma
Locally Advanced
Metastatic
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Lung cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Prostate cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M8
Metastatic Hormone-sensitive
Metastatic Castration-resistant
1
2
3 or more
Chemotherapy
Hormone therapy
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
CLL & Richter's syndrome
#NCT04623541
CLL (Chronic Lymphocytic Leukemia)
None
1
2
3 or more
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Genmab
Phase 1 / Phase 2
Endometrial cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M7
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
1
2
Immunotherapy
Chemotherapy
ARID1A
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Lung cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT04104776
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M1
Urothelial carcinoma
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lymphoma
#NCT04623541
B cell lymphoma
Lymphocytic lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Genmab